Clinical Research Directory
Browse clinical research sites, groups, and studies.
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
Sponsor: Pfizer
Summary
This study is to determine if inhaled insulin is effective in treating type 2 diabetes mellitus.
Official title: A Six Month, Open Label, Randomized Parallel Group Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera) On Glycemic Control Compared To Insulin Glargine (Lantus) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Or More Oral Agents
Key Details
Gender
All
Age Range
30 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
413
Start Date
2007-03
Completion Date
2008-08
Last Updated
2026-08-11
Healthy Volunteers
No
Conditions
Interventions
Insulin glargine
Insulin glargine, label instruction initiation dose (10 units), and individually adjusted doses, per subject's blood glucose, over the six months study, in addition to oral agents.
Inhaled Insulin (Exubera)
Initiation dose of one mg per meal, and individually adjusted doses, per subject's blood glucose, over the six months study, in addition to oral agents.
Locations (73)
Pfizer Investigational Site
Phoenix, Arizona, United States
Pfizer Investigational Site
Tucson, Arizona, United States
Pfizer Investigational Site
Concord, California, United States
Pfizer Investigational Site
Encino, California, United States
Pfizer Investigational Site
Fresno, California, United States
Pfizer Investigational Site
Fullerton, California, United States
Pfizer Investigational Site
Long Beach, California, United States
Pfizer Investigational Site
Mission Viejo, California, United States
Pfizer Investigational Site
Pasadena, California, United States
Pfizer Investigational Site
San Diego, California, United States
Pfizer Investigational Site
San Diego, California, United States
Pfizer Investigational Site
San Luis Obispo, California, United States
Pfizer Investigational Site
Spring Valley, California, United States
Pfizer Investigational Site
Stockton, California, United States
Pfizer Investigational Site
Walnut Creek, California, United States
Pfizer Investigational Site
West Hills, California, United States
Pfizer Investigational Site
Golden, Colorado, United States
Pfizer Investigational Site
Waterbury, Connecticut, United States
Pfizer Investigational Site
Newark, Delaware, United States
Pfizer Investigational Site
Chiefland, Florida, United States
Pfizer Investigational Site
Clearwater, Florida, United States
Pfizer Investigational Site
Hollywood, Florida, United States
Pfizer Investigational Site
Kissimmee, Florida, United States
Pfizer Investigational Site
Miami, Florida, United States
Pfizer Investigational Site
Ocala, Florida, United States
Pfizer Investigational Site
Saint Cloud, Florida, United States
Pfizer Investigational Site
Winter Park, Florida, United States
Pfizer Investigational Site
Atlanta, Georgia, United States
Pfizer Investigational Site
Lawrenceville, Georgia, United States
Pfizer Investigational Site
Lawrenceville, Georgia, United States
Pfizer Investigational Site
Woodstock, Georgia, United States
Pfizer Investigational Site
Boise, Idaho, United States
Pfizer Investigational Site
Hayden Lake, Idaho, United States
Pfizer Investigational Site
Indianapolis, Indiana, United States
Pfizer Investigational Site
Overland Park, Kansas, United States
Pfizer Investigational Site
Topeka, Kansas, United States
Pfizer Investigational Site
Lexington, Kentucky, United States
Pfizer Investigational Site
Louisville, Kentucky, United States
Pfizer Investigational Site
Baton Rouge, Louisiana, United States
Pfizer Investigational Site
New Orleans, Louisiana, United States
Pfizer Investigational Site
Haverhill, Massachusetts, United States
Pfizer Investigational Site
Springfield, Missouri, United States
Pfizer Investigational Site
Omaha, Nebraska, United States
Pfizer Investigational Site
Las Vegas, Nevada, United States
Pfizer Investigational Site
Staten Island, New York, United States
Pfizer Investigational Site
Charlotte, North Carolina, United States
Pfizer Investigational Site
Statesville, North Carolina, United States
Pfizer Investigational Site
Winston-Salem, North Carolina, United States
Pfizer Investigational Site
Kettering, Ohio, United States
Pfizer Investigational Site
Maumee, Ohio, United States
Pfizer Investigational Site
Toledo, Ohio, United States
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States
Pfizer Investigational Site
Medford, Oregon, United States
Pfizer Investigational Site
Melrose Park, Pennsylvania, United States
Pfizer Investigational Site
Greenville, South Carolina, United States
Pfizer Investigational Site
Greer, South Carolina, United States
Pfizer Investigational Site
Spartanburg, South Carolina, United States
Pfizer Investigational Site
Milan, Tennessee, United States
Pfizer Investigational Site
Arlington, Texas, United States
Pfizer Investigational Site
Beaumont, Texas, United States
Pfizer Investigational Site
Dallas, Texas, United States
Pfizer Investigational Site
Dallas, Texas, United States
Pfizer Investigational Site
Dallas, Texas, United States
Pfizer Investigational Site
El Paso, Texas, United States
Pfizer Investigational Site
Houston, Texas, United States
Pfizer Investigational Site
Houston, Texas, United States
Pfizer Investigational Site
San Antonio, Texas, United States
Pfizer Investigational Site
San Antonio, Texas, United States
Pfizer Investigational Site
Bennington, Vermont, United States
Pfizer Investigational Site
Richmond, Virginia, United States
Pfizer Investigational Site
Federal Way, Washington, United States
Pfizer Investigational Site
Menomonee Falls, Wisconsin, United States
Pfizer Investigational Site
Carolina, Puerto Rico